Back
Tandem Diabetes Care Vs. RxSight Industry Stock Comparison
Sell
22
TNDM
Tandem Diabetes Care
Last Price:
28.56
Seasonality Move:
9.63%
Sell
6
RXST
RxSight
Last Price:
44.19
Seasonality Move:
35.42%
Sell
22
Tandem Diabetes Care (TNDM)
is a Sell
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $29.67. The Score for TNDM is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- TNDM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
RxSight (RXST)
is a Sell
Is RxSight a Buy, Sell or Hold?
- The current RxSight [RXST] share price is $44.65. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $29.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNDM is experiencing selling pressure, which indicates risk of future bearish movement.
RXST Stock Price Chart
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.02 | Sell |
| Relative Strength Index (14 RSI): | 32.06 | Sell |
| Chaikin Money Flow: | -969333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.13 - 36.11) | Sell |
| Bollinger Bands (100): | (35.54 - 44.5) | Sell |
RXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 33.75 | Sell |
| Chaikin Money Flow: | -198994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.85 - 51.99) | Sell |
| Bollinger Bands (100): | (47.12 - 54.96) | Sell |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.03 | Sell |
| 20-day SMA: | 32.66 | Sell |
| 50-day SMA: | 38.17 | Sell |
| 200-day SMA: | 37.89 | Sell |
| 8-day EMA: | 31.5 | Sell |
| 20-day EMA: | 33.21 | Sell |
| 50-day EMA: | 36.54 | Sell |
| 200-day EMA: | 37.48 | Sell |
RXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.12 | Sell |
| 20-day SMA: | 49.93 | Sell |
| 50-day SMA: | 50.74 | Sell |
| 200-day SMA: | 52.84 | Sell |
| 8-day EMA: | 47.91 | Sell |
| 20-day EMA: | 49.34 | Sell |
| 50-day EMA: | 50.34 | Sell |
| 200-day EMA: | 49.06 | Sell |
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.51 per share.
RxSight Earnings Growth & RXST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.
Tandem Diabetes Care Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RxSight Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||